- Home
- VSTE vs ONCY Comparison
VSTE vs ONCY Comparison
Compare VSTE & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- ONCY
- Stock Information
- Founded
- VSTE 2009
- ONCY 1998
- Country
- VSTE Australia
- ONCY Canada
- Employees
- VSTE N/A
- ONCY N/A
- Industry
- VSTE
- ONCY Pharmaceuticals and Biotechnology
- Sector
- VSTE
- ONCY Health Care
- Exchange
- VSTE Nasdaq
- ONCY Nasdaq
- Market Cap
- VSTE 30.0M
- ONCY 103.8M
- IPO Year
- VSTE N/A
- ONCY 1999
- Fundamental
- Price
- VSTE $2.42
- ONCY $1.19
- Analyst Decision
- VSTE
- ONCY Strong Buy
- Analyst Count
- VSTE 0
- ONCY 2
- Target Price
- VSTE N/A
- ONCY $4.00
- AVG Volume (30 Days)
- VSTE 14.1K
- ONCY 903.7K
- Earning Date
- VSTE 01-01-0001
- ONCY 11-05-2024
- Dividend Yield
- VSTE N/A
- ONCY N/A
- EPS Growth
- VSTE N/A
- ONCY N/A
- EPS
- VSTE N/A
- ONCY N/A
- Revenue
- VSTE $342,000.00
- ONCY N/A
- Revenue This Year
- VSTE N/A
- ONCY N/A
- Revenue Next Year
- VSTE N/A
- ONCY N/A
- P/E Ratio
- VSTE N/A
- ONCY N/A
- Revenue Growth
- VSTE N/A
- ONCY N/A
- 52 Week Low
- VSTE $0.83
- ONCY $0.84
- 52 Week High
- VSTE $12.00
- ONCY $1.80
- Technical
- Relative Strength Index (RSI)
- VSTE 55.09
- ONCY 52.51
- Support Level
- VSTE $0.83
- ONCY $1.17
- Resistance Level
- VSTE $1.09
- ONCY $1.28
- Average True Range (ATR)
- VSTE 0.10
- ONCY 0.09
- MACD
- VSTE 0.03
- ONCY -0.01
- Stochastic Oscillator
- VSTE 92.08
- ONCY 28.00
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.